Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

614 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials.
Brightling CE, Gaga M, Inoue H, Li J, Maspero J, Wenzel S, Maitra S, Lawrence D, Brockhaus F, Lehmann T, Brindicci C, Knorr B, Bleecker ER. Brightling CE, et al. Among authors: maitra s. Lancet Respir Med. 2021 Jan;9(1):43-56. doi: 10.1016/S2213-2600(20)30412-4. Epub 2020 Sep 24. Lancet Respir Med. 2021. PMID: 32979986 Clinical Trial.
FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease.
Mahler DA, Kerwin E, Ayers T, FowlerTaylor A, Maitra S, Thach C, Lloyd M, Patalano F, Banerji D. Mahler DA, et al. Among authors: maitra s. Am J Respir Crit Care Med. 2015 Nov 1;192(9):1068-79. doi: 10.1164/rccm.201505-1048OC. Am J Respir Crit Care Med. 2015. PMID: 26177074 Clinical Trial.
Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over Studies.
Kerwin E, Ferguson GT, Sanjar S, Goodin T, Yadao A, Fogel R, Maitra S, Sen B, Ayers T, Banerji D. Kerwin E, et al. Among authors: maitra s. Lung. 2017 Dec;195(6):739-747. doi: 10.1007/s00408-017-0055-9. Epub 2017 Oct 9. Lung. 2017. PMID: 28993871 Clinical Trial.
Teriparatide and osseous regeneration in the oral cavity.
Bashutski JD, Eber RM, Kinney JS, Benavides E, Maitra S, Braun TM, Giannobile WV, McCauley LK. Bashutski JD, et al. Among authors: maitra s. N Engl J Med. 2010 Dec 16;363(25):2396-405. doi: 10.1056/NEJMoa1005361. Epub 2010 Oct 16. N Engl J Med. 2010. PMID: 20950166 Free PMC article. Clinical Trial.
The impact of vitamin D status on periodontal surgery outcomes.
Bashutski JD, Eber RM, Kinney JS, Benavides E, Maitra S, Braun TM, Giannobile WV, McCauley LK. Bashutski JD, et al. Among authors: maitra s. J Dent Res. 2011 Aug;90(8):1007-12. doi: 10.1177/0022034511407771. Epub 2011 May 9. J Dent Res. 2011. PMID: 21555774 Free PMC article. Clinical Trial.
Publisher Correction: Development and characterization of a self-nano emulsifying drug delivery system (SNEDDS) for Ornidazole to improve solubility and oral bioavailability of BCS class II drugs.
Mohite P, Sule S, Pawar A, Alharbi HM, Maitra S, Subramaniyan V, Kumarasamy V, Uti DE, Ogbu CO, Oodo SI, Kumer A, Idowu AO, Okoye ONN. Mohite P, et al. Among authors: maitra s. Sci Rep. 2024 Dec 19;14(1):30556. doi: 10.1038/s41598-024-82249-2. Sci Rep. 2024. PMID: 39702663 Free PMC article. No abstract available.
Development and characterization of a self-nano emulsifying drug delivery system (SNEDDS) for Ornidazole to improve solubility and oral bioavailability of BCS class II drugs.
Mohite P, Sule S, Pawar A, Alharbi HM, Maitra S, Subramaniyan V, Kumarasamy V, Uti DE, Ogbu CO, Oodo SI, Kumer A, Idowu AO, Okoye ONN. Mohite P, et al. Among authors: maitra s. Sci Rep. 2024 Nov 12;14(1):27724. doi: 10.1038/s41598-024-73760-7. Sci Rep. 2024. PMID: 39532892 Free PMC article.
614 results